Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study) - Concepedia

Concepedia

Publication | Open Access

Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study)

DOI Full Paper Access

28

Citations

19

References

2014

Year

Paulo Caramelli, Jerson Laks, André Palmini, Ricardo Nitríni, Márcia Lorena Fagundes Chaves, Orestes Vicente Forlenza, Francisco de Assis Carvalho do Vale, Maira Tonidandel Barbosa, Cássio Machado de Campos Bottino, João Carlos Machado,

Arquivos de Neuro-Psiquiatria

Abstract

GAL treatment improved QoL in mixed dementia, in addition to its previously known cognitive benefits. The combination GAL/NIM was not advantageous. However, the small sample size precludes any definitive conclusions. Trial registered at ClinicalTrials.gov: NCT00814658.

References

	Year	Citations

Page 1